PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle-Upon-Tyne, NE1 4LP, UK. lydia.stone1@nhs.net.\', \'Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle-Upon-Tyne, NE1 4LP, UK.\', \'Gloucestershire Retinal Research Group, Above Oakley Ward, Cheltenham General Hospital, Sandford Road, Cheltenham, Gloucestershire, GL53 7AN, UK.\', \'Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle-Upon-Tyne, NE1 4LP, UK. james.talks@nhs.net.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s00417-020-04849-8
?:hasPublicationType
?:journal
  • Graefe\'s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
is ?:pmid of
?:pmid
?:pmid
  • 32712708
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Macula service evaluation and assessing priorities for anti-VEGF treatment in the light of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all